Journalist and news reader Peter Overton our new National Ambassador
23 November 2021
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
Peter is a familiar face across Australia, spending the past 30 years as a journalist and news reader with the Nine Network. Having travelled the world to cover major world events including September 11 and the Bali bombings, and as a reporter with 60 minutes for nearly a decade, Peter is used to being on the news front line.
What Peter didn’t expect was to become the news - when he was first diagnosed with melanoma in November 2020. Peter underwent immediate surgery to remove the melanoma on his temple, which meant a stint in hospital and time away from the news desk. On his first night back on air, Peter selflessly shared his personal story, including his still healing surgical scars, as a warning to others to be sun safe and check their skin for changes.
Peter has since found three more melanomas on his back, requiring three more operations. Peter knows he is lucky as all his melanomas were caught early and removed before they had spread. With a high mole count, a childhood spent in the sun, and now with a history of melanoma, Peter is in a high risk group and undergoes regular screening and checks at Melanoma Institute Australia.
‘I am living proof that early detection saves lives, and as a proud dad to two teenage daughters, I am passionate about reaching young Australians with sun safety and early detection messages,’ Peter said. ‘I am delighted to be a National Ambassador for Melanoma Institute Australia which is focused on not only raising awareness, but which also leads global research efforts to find a cure for melanoma.’
‘We thank Peter for his generosity and passion in sharing his personal melanoma story to raise awareness about the disease, and also the importance of knowing your skin,’ said Melanoma Institute Australia CEO Matthew Browne. ‘Peter used his public profile to support our Game On Mole campaign in 2020 and 2021, and we are delighted to have him now join our organisation as National Ambassador. We look forward to working with Peter as we continue towards our mission of reaching zero deaths from melanoma.’
Watch the 9News segment where Peter discusses his melanoma experience and interviews MIA's Dr. Annika Smith:
Peter joins Olympic swimming champion Cate Campbell as National Ambassador, and Ninja athlete Olivia Vivian, rugby great John Eales, personal trainer Shannan Ponton, and more recently our Game On Mole Ambassador Oceana Strachan, as valued MIA Ambassadors all impacted by melanoma who continued this year to generously donate their time to help us raise awareness and vital funds for research.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.